Form 8-K - Current report:
SEC Accession No. 0000950170-22-011825
Filing Date
2022-06-17
Accepted
2022-06-17 17:20:17
Documents
12
Period of Report
2022-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20220616.htm   iXBRL 8-K 51660
  Complete submission text file 0000950170-22-011825.txt   164800

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fgen-20220616_lab.xml EX-101.LAB 12798
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fgen-20220616_pre.xml EX-101.PRE 9453
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fgen-20220616.xsd EX-101.SCH 2469
6 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20220616_htm.xml XML 4509
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 221025105
SIC: 2834 Pharmaceutical Preparations